Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

Standard

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS). / Mossner, M; Jann, J-C; Nowak, D; Platzbecker, U; Giagounidis, A; Götze, K; Letsch, A; Haase, D; Shirneshan, K; Braulke, F; Schlenk, R F; Haferlach, T; Schafhausen, P; Bug, G; Lübbert, M; Ganser, A; Büsche, G; Schuler, E; Nowak, V; Pressler, J; Obländer, J; Fey, S; Müller, N; Lauinger-Lörsch, E; Metzgeroth, G; Weiß, C; Hofmann, W-K; Germing, U; Nolte, F.

in: LEUKEMIA, Jahrgang 30, Nr. 9, 09.2016, S. 1956-9.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungAndere (Vorworte u.ä.)Forschung

Harvard

Mossner, M, Jann, J-C, Nowak, D, Platzbecker, U, Giagounidis, A, Götze, K, Letsch, A, Haase, D, Shirneshan, K, Braulke, F, Schlenk, RF, Haferlach, T, Schafhausen, P, Bug, G, Lübbert, M, Ganser, A, Büsche, G, Schuler, E, Nowak, V, Pressler, J, Obländer, J, Fey, S, Müller, N, Lauinger-Lörsch, E, Metzgeroth, G, Weiß, C, Hofmann, W-K, Germing, U & Nolte, F 2016, 'Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)', LEUKEMIA, Jg. 30, Nr. 9, S. 1956-9. https://doi.org/10.1038/leu.2016.111

APA

Mossner, M., Jann, J-C., Nowak, D., Platzbecker, U., Giagounidis, A., Götze, K., Letsch, A., Haase, D., Shirneshan, K., Braulke, F., Schlenk, R. F., Haferlach, T., Schafhausen, P., Bug, G., Lübbert, M., Ganser, A., Büsche, G., Schuler, E., Nowak, V., ... Nolte, F. (2016). Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS). LEUKEMIA, 30(9), 1956-9. https://doi.org/10.1038/leu.2016.111

Vancouver

Bibtex

@article{fdfb09ddaa85480abd70e31833f22c7c,
title = "Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)",
keywords = "Journal Article",
author = "M Mossner and J-C Jann and D Nowak and U Platzbecker and A Giagounidis and K G{\"o}tze and A Letsch and D Haase and K Shirneshan and F Braulke and Schlenk, {R F} and T Haferlach and P Schafhausen and G Bug and M L{\"u}bbert and A Ganser and G B{\"u}sche and E Schuler and V Nowak and J Pressler and J Obl{\"a}nder and S Fey and N M{\"u}ller and E Lauinger-L{\"o}rsch and G Metzgeroth and C Wei{\ss} and W-K Hofmann and U Germing and F Nolte",
year = "2016",
month = sep,
doi = "10.1038/leu.2016.111",
language = "English",
volume = "30",
pages = "1956--9",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "9",

}

RIS

TY - JOUR

T1 - Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

AU - Mossner, M

AU - Jann, J-C

AU - Nowak, D

AU - Platzbecker, U

AU - Giagounidis, A

AU - Götze, K

AU - Letsch, A

AU - Haase, D

AU - Shirneshan, K

AU - Braulke, F

AU - Schlenk, R F

AU - Haferlach, T

AU - Schafhausen, P

AU - Bug, G

AU - Lübbert, M

AU - Ganser, A

AU - Büsche, G

AU - Schuler, E

AU - Nowak, V

AU - Pressler, J

AU - Obländer, J

AU - Fey, S

AU - Müller, N

AU - Lauinger-Lörsch, E

AU - Metzgeroth, G

AU - Weiß, C

AU - Hofmann, W-K

AU - Germing, U

AU - Nolte, F

PY - 2016/9

Y1 - 2016/9

KW - Journal Article

U2 - 10.1038/leu.2016.111

DO - 10.1038/leu.2016.111

M3 - Other (editorial matter etc.)

C2 - 27133825

VL - 30

SP - 1956

EP - 1959

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 9

ER -